2000 Session

Budget Amendments - SB30 (Conference Report)

View Budget Item
View Budget Item amendments

Rising Cost of Pharmaceuticals Study (language only)

Item 266 #1c

Item 266 #1c

Finance, Secretary of

Page 210, strike lines 38 through 47 and insert:
"C.  The Secretary of Finance, in cooperation with the Secretaries of Administration and Health and Human Resources, shall conduct a study of the rising utilization of pharmaceuticals in government-funded healthcare programs in Virginia.  The study shall include cost trends; drivers of cost trends; the impact that higher utilization has on overall healthcare; the impact that increased pharmaceutical utilization has on the quality of patient care; and the future budgetary impact and potential savings to all healthcare segments within government-funded healthcare programs.  The Secretary of Finance shall establish an advisory group to assist in the conduct of the study.  The advisory group shall be composed of two representatives of patient advocacy organizations, to be selected by the Virginia Quality Health Care Network, and one representative from each of the following organizations, as selected by the named organizations:  the Medical Society of Virginia, the Old Dominion Medical Society, the Virginia Hospital and Healthcare Association, the Virginia Association of Health Plans, the Virginia Pharmacists Association, the Virginia Society of Health-System Pharmacists, and the Pharmaceutical Research and Manufacturers of America.  The Secretaries shall present their report to the Governor and the Chairmen of the House Appropriations and Senate Finance Committees by October 20, 2000."

(This amendment is self-explanatory.)